Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gazitt, Y
   Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   Y. Gazitt, "Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules", J HEMATH ST, 10(2), 2001, pp. 229-236
2. Gazitt, Y; Shaughnessy, P; Liu, Q
   Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   Y. Gazitt et al., "Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors", J HEMATH ST, 10(1), 2001, pp. 167-176
3. Gazitt, Y; Shaughnessy, P; Devore, P
   Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   Y. Gazitt et al., "Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors", J HEMATH ST, 10(1), 2001, pp. 177-186
4. Gazitt, Y; Shaughnessy, P; Liu, Q
   Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors
   STEM CELLS
   
   Y. Gazitt et al., "Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors", STEM CELLS, 19(2), 2001, pp. 134-143
5. Gazitt, Y; Liu, Q
   Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients
   STEM CELLS
   
   Y. Gazitt e Q. Liu, "Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients", STEM CELLS, 19(1), 2001, pp. 37-45
6. Kim, K; Takimoto, R; Dicker, DT; Chen, YH; Gazitt, Y; El-Deiry, WS
   Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   K. Kim et al., "Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines", INT J ONCOL, 18(2), 2001, pp. 241-247
7. Liu, Q; El-Deiry, WS; Gazitt, Y
   Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines
   EXPERIMENTAL HEMATOLOGY
   
   Q. Liu et al., "Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines", EXP HEMATOL, 29(8), 2001, pp. 962-970
8. Gazitt, Y; Reddy, SV; Alcantara, O; Yang, J; Boldt, DH
   A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate
   JOURNAL OF CELLULAR PHYSIOLOGY
   
   Y. Gazitt et al., "A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate", J CELL PHYS, 187(1), 2001, pp. 124-135
9. Anderson, JE; Tefferi, A; Craig, F; Holmberg, L; Chauncey, T; Appelbaum, FR; Guardiola, P; Callander, N; Freytes, C; Gazitt, Y; Razvillas, B; Deeg, HJ
   Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis
   BLOOD
   
   J.E. Anderson et al., "Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis", BLOOD, 98(3), 2001, pp. 586-593
10. Gazitt, Y; Callander, N; Freytes, CO; Shaughnessy, P; Liu, Q; Tsai, TW; Devore, P
    Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    Y. Gazitt et al., "Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study", J HEMATH ST, 9(5), 2000, pp. 737-748
11. Gazitt, Y; Liu, Q
    High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34(+) PBSC in patients undergoing high-dose chemotherapy and stem cell rescue
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    Y. Gazitt e Q. Liu, "High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34(+) PBSC in patients undergoing high-dose chemotherapy and stem cell rescue", J HEMATH ST, 9(2), 2000, pp. 285-293
12. Gazitt, Y
    Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors
    STEM CELLS
    
    Y. Gazitt, "Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors", STEM CELLS, 18(6), 2000, pp. 390-398
13. Liu, Q; Gazitt, Y
    Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes
    EXPERIMENTAL HEMATOLOGY
    
    Q. Liu e Y. Gazitt, "Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes", EXP HEMATOL, 28(12), 2000, pp. 1354-1362
14. Gazitt, Y; Freytes, CO; Callander, N; Tsai, TW; Alsina, M; Anderson, J; Holle, L; Cruz, J; Devoer, P; McGrath, M; West, G; Alvarez, R; Montgomery, W
    Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization
    JOURNAL OF HEMATOTHERAPY
    
    Y. Gazitt et al., "Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization", J HEMATOTH, 8(2), 1999, pp. 173-183
15. Gazitt, Y; Shaughnessy, P; Montgomery, W
    Apoptosis-induced by trail and TNF-alpha in human multiple myeloma cells is not blocked by bcl-2
    CYTOKINE
    
    Y. Gazitt et al., "Apoptosis-induced by trail and TNF-alpha in human multiple myeloma cells is not blocked by bcl-2", CYTOKINE, 11(12), 1999, pp. 1010-1019
16. Gazitt, Y
    TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
    LEUKEMIA
    
    Y. Gazitt, "TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells", LEUKEMIA, 13(11), 1999, pp. 1817-1824
17. Menaa, C; Devlin, RD; Reddy, SV; Gazitt, Y; Choi, SJ; Roodman, GD
    Annexin II increases osteoclast formation by stimulating the proliferationof osteoclast precursors in human marrow cultures
    JOURNAL OF CLINICAL INVESTIGATION
    
    C. Menaa et al., "Annexin II increases osteoclast formation by stimulating the proliferationof osteoclast precursors in human marrow cultures", J CLIN INV, 103(11), 1999, pp. 1605-1613
18. GAZITT Y; ROTHENBERG ML; HILSENBECK SG; FEY V; THOMAS C; MONTEGOMREY W
    BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS
    International journal of oncology
    
    Y. Gazitt et al., "BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS", International journal of oncology, 13(4), 1998, pp. 839-848
19. GAZITT Y; FEY V; THOMAS C; ALVAREZ R
    BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO DEXAMETHASONE, BUT NOT MELPHALAN, IN MULTIPLE-MYELOMA CELLS
    International journal of oncology
    
    Y. Gazitt et al., "BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO DEXAMETHASONE, BUT NOT MELPHALAN, IN MULTIPLE-MYELOMA CELLS", International journal of oncology, 13(2), 1998, pp. 397-405
20. GAZITT Y; HU WX
    FAS (APO-1 CD95)-MEDIATED APOPTOSIS IS INDEPENDENT OF BCL-2 - A STUDYWITH CELL-LINES OVEREXPRESSING BCL-2 AND WITH BCL-2 TRANSFECTED CELL LIMES/
    International journal of oncology
    
    Y. Gazitt e W.X. Hu, "FAS (APO-1 CD95)-MEDIATED APOPTOSIS IS INDEPENDENT OF BCL-2 - A STUDYWITH CELL-LINES OVEREXPRESSING BCL-2 AND WITH BCL-2 TRANSFECTED CELL LIMES/", International journal of oncology, 12(1), 1998, pp. 211-220
21. TRICOT G; GAZITT Y; LEEMHUIS T; JAGANNATH S; DESIKAN KR; SIEGEL D; FASSAS A; TINDLE S; NELSON J; JUTTNER C; TSUKAMOTO A; HALLAGAN J; ATKINSON K; READING C; HOFFMAN R; BARLOGIE B
    COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA
    Blood
    
    G. Tricot et al., "COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA", Blood, 91(12), 1998, pp. 4489-4495
22. GAZITT Y; HILSENBECK SG
    PITFALLS IN THE RNA-BASED PCR AMPLIFICATION OF THE CDRIII SEQUENCE FOR QUANTITATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE-MYELOMA (COMMENTARY)
    Oncology Reports
    
    Y. Gazitt e S.G. Hilsenbeck, "PITFALLS IN THE RNA-BASED PCR AMPLIFICATION OF THE CDRIII SEQUENCE FOR QUANTITATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE-MYELOMA (COMMENTARY)", Oncology Reports, 4(6), 1997, pp. 1387-1390
23. JETHMALANI SM; HENLE KJ; GAZITT Y; WALKER PD; WANG SY
    INTRACELLULAR-DISTRIBUTION OF HEAT-INDUCED STRESS GLYCOPROTEINS
    Journal of cellular biochemistry
    
    S.M. Jethmalani et al., "INTRACELLULAR-DISTRIBUTION OF HEAT-INDUCED STRESS GLYCOPROTEINS", Journal of cellular biochemistry, 66(1), 1997, pp. 98-111
24. GAZITT Y; REDDY SV; TSAI T; ALCANTARA O; YANG J; BOLDT DH
    IRON DEPRIVATION BLOCKS BOTH CELL CYCLING AND DIFFERENTIATION AND INDUCES APOPTOSIS IN HL60 LEUKEMIA-CELLS INDUCED TO DIFFERENTIATE WITH PHORBOL-MYRISTATE ACETATE (PMA)
    Blood
    
    Y. Gazitt et al., "IRON DEPRIVATION BLOCKS BOTH CELL CYCLING AND DIFFERENTIATION AND INDUCES APOPTOSIS IN HL60 LEUKEMIA-CELLS INDUCED TO DIFFERENTIATE WITH PHORBOL-MYRISTATE ACETATE (PMA)", Blood, 90(10), 1997, pp. 230-230
25. GAZITT Y; ROTHENBERG M; FEY V; MONTGOMERY W; ALVAREZ R
    GEMCITABINE (GEM) IS A PANCYTOTOXIC DRUG FOR VARIOUS MULTIPLE-MYELOMA(MM) CELL-LINES, WHEREAS TAXOL (TAX) CYTOTOXICITY IS DEPENDENT ON THEEXPRESSION OF BCL-2
    Blood
    
    Y. Gazitt et al., "GEMCITABINE (GEM) IS A PANCYTOTOXIC DRUG FOR VARIOUS MULTIPLE-MYELOMA(MM) CELL-LINES, WHEREAS TAXOL (TAX) CYTOTOXICITY IS DEPENDENT ON THEEXPRESSION OF BCL-2", Blood, 90(10), 1997, pp. 1455-1455
26. GAZITT Y; READING CL
    AUTOLOGOUS TRANSPLANTATION WITH TUMOR-FREE GRAFT - A MODEL FOR MULTIPLE-MYELOMA PATIENTS
    Leukemia & lymphoma
    
    Y. Gazitt e C.L. Reading, "AUTOLOGOUS TRANSPLANTATION WITH TUMOR-FREE GRAFT - A MODEL FOR MULTIPLE-MYELOMA PATIENTS", Leukemia & lymphoma, 23(3-4), 1996, pp. 203-212
27. GAZITT Y
    THE ARKANSAS-CANCER-RESEARCH-CENTER, LITTLE-ROCK, AR, USA
    Oncology Reports
    
    Y. Gazitt, "THE ARKANSAS-CANCER-RESEARCH-CENTER, LITTLE-ROCK, AR, USA", Oncology Reports, 3(5), 1996, pp. 811-812
28. HU WX; GAZITT Y
    BCL-2 PLAYS A MAJOR ROLE IN RESISTANCE TO DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES
    International journal of oncology
    
    W.X. Hu e Y. Gazitt, "BCL-2 PLAYS A MAJOR ROLE IN RESISTANCE TO DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES", International journal of oncology, 9(2), 1996, pp. 375-381
29. TIAN EM; HU WX; GAZITT Y
    BCL-2 PLAYS A CRITICAL ROLE IN GROWTH AND IN SPONTANEOUS OR INDUCED APOPTOSIS IN MYELOMA CELL-LINES - A STUDY WITH INDUCIBLE BCL-2 TRANSFECTION CONSTRUCTS
    International journal of oncology
    
    E.M. Tian et al., "BCL-2 PLAYS A CRITICAL ROLE IN GROWTH AND IN SPONTANEOUS OR INDUCED APOPTOSIS IN MYELOMA CELL-LINES - A STUDY WITH INDUCIBLE BCL-2 TRANSFECTION CONSTRUCTS", International journal of oncology, 9(1), 1996, pp. 165-169
30. TIAN EM; GAZITT Y
    THE ROLE OF P53, BCL-2 AND BAX NETWORK IN DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES
    International journal of oncology
    
    E.M. Tian e Y. Gazitt, "THE ROLE OF P53, BCL-2 AND BAX NETWORK IN DEXAMETHASONE-INDUCED APOPTOSIS IN MULTIPLE-MYELOMA CELL-LINES", International journal of oncology, 8(4), 1996, pp. 719-726
31. JAGANNATH TG; HAGANNATH S; BARLOGIE B; HOFFMAN R; READING C; ATKINSON K; GAZITT Y
    AUTOLOGOUS TRANSPLANTATION OF MULTIPLE-MYELOMA PATIENTS WITH FLOW-SORTED CD34-STEM CELLS PROVIDES VIRTUALLY TUMOR-FREE GRAFTS(THY+LIN)
    Blood
    
    T.G. Jagannath et al., "AUTOLOGOUS TRANSPLANTATION OF MULTIPLE-MYELOMA PATIENTS WITH FLOW-SORTED CD34-STEM CELLS PROVIDES VIRTUALLY TUMOR-FREE GRAFTS(THY+LIN)", Blood, 88(10), 1996, pp. 1012-1012
32. GAZITT Y; TIAN EM; BARLOGIE B; READING CL; VESOLE DH; JAGANNATH S; SCHNELL J; HOFFMAN R; TRICOT G
    DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA AFTER TREATMENT WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    Blood
    
    Y. Gazitt et al., "DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA AFTER TREATMENT WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR", Blood, 87(2), 1996, pp. 805-811
33. GAZITT Y; TIAN E; BARLOGIE B; GROVE C; READING CC; VESOLE DH; JAGANNATH S; SCHNELL J; HOFFMAN R; TRICOT G
    DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA PATIENTS FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE AND GM-CSF
    Experimental hematology
    
    Y. Gazitt et al., "DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA PATIENTS FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE AND GM-CSF", Experimental hematology, 23(8), 1995, pp. 803-803
34. GAZITT Y; LEE JH; TIAN E; GROVE C; BARLOGIE B; TRICOT G
    BCL-2 AND NOT BAX PROTEINS IS THE RATE-LIMITING STEP IN DEXAMETHASONE(DEX)-INDUCED APOPTOSIS IN MYELOMA
    Experimental hematology
    
    Y. Gazitt et al., "BCL-2 AND NOT BAX PROTEINS IS THE RATE-LIMITING STEP IN DEXAMETHASONE(DEX)-INDUCED APOPTOSIS IN MYELOMA", Experimental hematology, 23(8), 1995, pp. 891-891
35. TIAN E; LEE JH; TRICOT G; BARLOGIE B; GAZITT Y
    BCL-2 AND NOT BAX PROTEIN IS THE RATE-LIMITING STEP IN DEXAMETHASONE (DEX)-INDUCED APOPTOSIS IN MYELOMA CELLS
    Blood
    
    E. Tian et al., "BCL-2 AND NOT BAX PROTEIN IS THE RATE-LIMITING STEP IN DEXAMETHASONE (DEX)-INDUCED APOPTOSIS IN MYELOMA CELLS", Blood, 86(10), 1995, pp. 230-230
36. TRICOT G; GAZITT Y; JAGANNATH S; VESOLE D; READING C; JUTTNER C; HOFFMAN R; BARLOGIE B
    CD34- PERIPHERAL-BLOOD STEM-CELLS (PBSC) EFFECT TIMELY TRILINEAGE ENGRAFTMENT IN MULTIPLE-MYELOMA (MM)(THY+LIN)
    Blood
    
    G. Tricot et al., "CD34- PERIPHERAL-BLOOD STEM-CELLS (PBSC) EFFECT TIMELY TRILINEAGE ENGRAFTMENT IN MULTIPLE-MYELOMA (MM)(THY+LIN)", Blood, 86(10), 1995, pp. 1160-1160
37. JAZIEH AR; GAZITT Y
    VITAMIN-D STIMULATES CFU-GM COLONIES AND OSTEOCLAST FORMATION IN BONE-MARROW OF MULTIPLE-MYELOMA (MM) PATIENTS
    Blood
    
    A.R. Jazieh e Y. Gazitt, "VITAMIN-D STIMULATES CFU-GM COLONIES AND OSTEOCLAST FORMATION IN BONE-MARROW OF MULTIPLE-MYELOMA (MM) PATIENTS", Blood, 86(10), 1995, pp. 3331-3331
38. TRICOT G; BARLOGIE B; JAGANNATH S; VESOLE D; NAUCKE S; TIAN E; GAZITT Y
    DOUBLE AUTOTRANSPLANTS CAN INDUCE MOLECULAR REMISSIONS (MCR) IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA (MM)
    Blood
    
    G. Tricot et al., "DOUBLE AUTOTRANSPLANTS CAN INDUCE MOLECULAR REMISSIONS (MCR) IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA (MM)", Blood, 86(10), 1995, pp. 3863-3863
39. GAZITT Y; READING CC; HOFFMAN R; WICKREMA A; VESOLE DH; JAGANNATH S; CONDINO J; LEE B; BARLOGIE B; TRICOT G
    PURIFIED CD34(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS() LIN()
    Blood
    
    Y. Gazitt et al., "PURIFIED CD34(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS() LIN()", Blood, 86(1), 1995, pp. 381-389
40. GAZITT Y; CANTOR A; KOZA S; GRAHAMPOLE J
    A SAFE PROCEDURE FOR TRANSPORTING BONE-MARROW FOR PURGING IN A CENTRAL LABORATORY
    Oncology Reports
    
    Y. Gazitt et al., "A SAFE PROCEDURE FOR TRANSPORTING BONE-MARROW FOR PURGING IN A CENTRAL LABORATORY", Oncology Reports, 1(1), 1994, pp. 241-244
41. AVRAHAM H; ERDOS GW; GAZITT Y
    DIFFERENTIAL EXPRESSION AND SUBCELLULAR-LOCALIZATION OF PROTEIN-KINASE-C, ALPHA, GAMMA, DELTA, XI AND ZETA ISOFORMS IN AGF T-CELLS - MODIFICATION DURING PMA-INDUCED DIFFERENTIATION
    International journal of oncology
    
    H. Avraham et al., "DIFFERENTIAL EXPRESSION AND SUBCELLULAR-LOCALIZATION OF PROTEIN-KINASE-C, ALPHA, GAMMA, DELTA, XI AND ZETA ISOFORMS IN AGF T-CELLS - MODIFICATION DURING PMA-INDUCED DIFFERENTIATION", International journal of oncology, 5(2), 1994, pp. 237-241
42. GAZITT Y; ROSENBERGER M; GRIPPO JF; LUCAS DA; PRANKERD RJ
    AROMATIC RETINOID ACID-DERIVATIVES ARE POTENT INDUCERS OF DIFFERENTIATION OF NEUROBLASTOMA-CELLS - STRUCTURE-FUNCTION RELATIONSHIP AND THE INVOLVEMENT OF THE NUCLEAR RETINOIC ACID RECEPTORS
    International journal of oncology
    
    Y. Gazitt et al., "AROMATIC RETINOID ACID-DERIVATIVES ARE POTENT INDUCERS OF DIFFERENTIATION OF NEUROBLASTOMA-CELLS - STRUCTURE-FUNCTION RELATIONSHIP AND THE INVOLVEMENT OF THE NUCLEAR RETINOIC ACID RECEPTORS", International journal of oncology, 5(2), 1994, pp. 243-251
43. GAZITT Y; ERDOS GW
    FLUCTUATIONS AND NUCLEAR TRANSLOCATION OF P53, C-MYC, CDC-2 AND PCNA PROTEINS DURING GROWTH AND COMMITMENT TO DIFFERENTIATION OF AGF CELLS
    International journal of oncology
    
    Y. Gazitt e G.W. Erdos, "FLUCTUATIONS AND NUCLEAR TRANSLOCATION OF P53, C-MYC, CDC-2 AND PCNA PROTEINS DURING GROWTH AND COMMITMENT TO DIFFERENTIATION OF AGF CELLS", International journal of oncology, 4(1), 1994, pp. 67-73
44. GAZITT Y; READING C; STEFANOVA R; BARLOGIE B; VESOLE D; JAQANNATH S; CONDINO J; LEE B; WICKREMA A; TRICOT G
    MYELOMA CELLS CAN BE EFFECTIVELY DEPLETED FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTING CD34-) STEM-CELLS(, THY(1)+, LIN()
    Experimental hematology
    
    Y. Gazitt et al., "MYELOMA CELLS CAN BE EFFECTIVELY DEPLETED FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTING CD34-) STEM-CELLS(, THY(1)+, LIN()", Experimental hematology, 22(8), 1994, pp. 802-802
45. ACKERMAN Z; WANDS JR; GAZITT Y; BRECHOT C; KEW MC; SHOUVAL D
    ENHANCEMENT OF HBSAG DETECTION IN SERUM OF PATIENTS WITH CHRONIC LIVER-DISEASE FOLLOWING REMOVAL OF CIRCULATING IMMUNE-COMPLEXES
    Journal of hepatology
    
    Z. Ackerman et al., "ENHANCEMENT OF HBSAG DETECTION IN SERUM OF PATIENTS WITH CHRONIC LIVER-DISEASE FOLLOWING REMOVAL OF CIRCULATING IMMUNE-COMPLEXES", Journal of hepatology, 20(3), 1994, pp. 398-404
46. GAZITT Y; ERDOS GW
    FLUCTUATIONS AND ULTRASTRUCTURAL-LOCALIZATION OF ONCOPROTEINS AND CELL-CYCLE REGULATORY PROTEINS DURING GROWTH AND APOPTOSIS OF SYNCHRONIZED AGF CELLS
    Cancer research
    
    Y. Gazitt e G.W. Erdos, "FLUCTUATIONS AND ULTRASTRUCTURAL-LOCALIZATION OF ONCOPROTEINS AND CELL-CYCLE REGULATORY PROTEINS DURING GROWTH AND APOPTOSIS OF SYNCHRONIZED AGF CELLS", Cancer research, 54(4), 1994, pp. 950-956
47. GAZITT Y; LEE JH; TIAN E; SAWYER J; TRICOT G
    DELETION OF THE RB OR P53 GENES IN HUMAN MULTIPLE-MYELOMA CELL-LINES DOES NOT RESULT IN DECREASED PROTEIN EXPRESSION WITH UP-REGULATION OF IL-6 AND INCREASED GROWTH-RATE
    Blood
    
    Y. Gazitt et al., "DELETION OF THE RB OR P53 GENES IN HUMAN MULTIPLE-MYELOMA CELL-LINES DOES NOT RESULT IN DECREASED PROTEIN EXPRESSION WITH UP-REGULATION OF IL-6 AND INCREASED GROWTH-RATE", Blood, 84(10), 1994, pp. 10000177-10000177
48. GAZITT Y; READING C; LEE JH; BARLOGIE B; VESOLE D; JAGANNATH S; LEE B; WICKREMA A; TRICOT G
    EFFECTIVE DEPLETION OF MYELOMA CELLS FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTION FOR CD34-CELLS(THY+LIN STEM)
    Blood
    
    Y. Gazitt et al., "EFFECTIVE DEPLETION OF MYELOMA CELLS FROM MOBILIZED PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY SELECTION FOR CD34-CELLS(THY+LIN STEM)", Blood, 84(10), 1994, pp. 10000353-10000353
49. GAZITT Y; READING C; LEE JH; BARLOGIE B; VESOLE D; JAGANNATH S; SIMONETTI D; DIGIUSTO R; SCHNELL J; ROSEN NR; TRICOT G
    DIFFERENTIAL PERIPHERAL-BLOOD MOBILIZATION OF TUMOR AND NORMAL HEMATOPOIETIC PROGENITOR CELLS (HPC) IN MULTIPLE-MYELOMA (MM)
    Blood
    
    Y. Gazitt et al., "DIFFERENTIAL PERIPHERAL-BLOOD MOBILIZATION OF TUMOR AND NORMAL HEMATOPOIETIC PROGENITOR CELLS (HPC) IN MULTIPLE-MYELOMA (MM)", Blood, 84(10), 1994, pp. 10000354-10000354
50. READING C; SASAKI D; LEEMHUIS T; TICHENOR E; CHEN B; TSAO M; GAZITT Y; TRICOT G; HOFFMAN R
    CLINICAL-SCALE PURIFICATION OF CD34-1+LIN-STEM CELLS FROM MOBILIZED PERIPHERAL-BLOOD BY HIGH-SPEED FLUORESCENCE-ACTIVATED CELL SORTING FOR USE AS AN AUTOGRAFT FOR MULTIPLE-MYELOMA PATIENTS(THY)
    Blood
    
    C. Reading et al., "CLINICAL-SCALE PURIFICATION OF CD34-1+LIN-STEM CELLS FROM MOBILIZED PERIPHERAL-BLOOD BY HIGH-SPEED FLUORESCENCE-ACTIVATED CELL SORTING FOR USE AS AN AUTOGRAFT FOR MULTIPLE-MYELOMA PATIENTS(THY)", Blood, 84(10), 1994, pp. 10000399-10000399
51. GAZITT Y; CANTOR A; HE YJ; KOZA S; COHEN RJ; GRAHAMPOLE J
    PROGNOSTIC FACTORS IN PURGED MARROW FROM PATIENTS WITH NEUROBLASTOMA RECEIVING MYELOABLATIVE TREATMENT - TUMOR-CELL NUMBER, N-MYC PROTEIN, N-MYC GENE AMPLIFICATION AND RATE OF HEMATOLOGIC RECOVERY
    International journal of oncology
    
    Y. Gazitt et al., "PROGNOSTIC FACTORS IN PURGED MARROW FROM PATIENTS WITH NEUROBLASTOMA RECEIVING MYELOABLATIVE TREATMENT - TUMOR-CELL NUMBER, N-MYC PROTEIN, N-MYC GENE AMPLIFICATION AND RATE OF HEMATOLOGIC RECOVERY", International journal of oncology, 3(4), 1993, pp. 755-761
52. GAZITT Y; LAVIA MF; ERDOS GW
    REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS
    International journal of oncology
    
    Y. Gazitt et al., "REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS", International journal of oncology, 3(3), 1993, pp. 489-496
53. GAZITT Y; HE YJ; SHULTS K; STELZER GT; COHEN RJ
    ISOLATION AND CHARACTERIZATION OF AN EARLY T-HELPER INDUCER CELL-LINEWITH A UNIQUE PATTERN OF SURFACE PHENOTYPE, CONSTITUTIVE CYTOKINE SECRETION AND MYC ONCOGENE EXPRESSION/
    Leukemia
    
    Y. Gazitt et al., "ISOLATION AND CHARACTERIZATION OF AN EARLY T-HELPER INDUCER CELL-LINEWITH A UNIQUE PATTERN OF SURFACE PHENOTYPE, CONSTITUTIVE CYTOKINE SECRETION AND MYC ONCOGENE EXPRESSION/", Leukemia, 7(12), 1993, pp. 2034-2044
54. GAZITT Y; ERDOS GW; COHEN RJ
    ULTRASTRUCTURAL-LOCALIZATION AND FLUCTUATION IN THE LEVEL OF THE PROLIFERATING CELL NUCLEAR ANTIGEN AND MYC ONCOPROTEINS IN SYNCHRONIZED NEUROBLASTOMA-CELLS
    Cancer research
    
    Y. Gazitt et al., "ULTRASTRUCTURAL-LOCALIZATION AND FLUCTUATION IN THE LEVEL OF THE PROLIFERATING CELL NUCLEAR ANTIGEN AND MYC ONCOPROTEINS IN SYNCHRONIZED NEUROBLASTOMA-CELLS", Cancer research, 53(8), 1993, pp. 1899-1905
55. TRICOT G; DAO D; GAZITT Y; EPSTEIN J; SAWYER J; HOOVER R; BARLOGIE B
    DELETION OF THE RETINOBLASTOMA GENE (RB-1) IN MULTIPLE-MYELOMA (MM)
    Blood
    
    G. Tricot et al., "DELETION OF THE RETINOBLASTOMA GENE (RB-1) IN MULTIPLE-MYELOMA (MM)", Blood, 82(10), 1993, pp. 10000261-10000261
56. GAZITT Y; ERDOS GW
    REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS
    Blood
    
    Y. Gazitt e G.W. Erdos, "REGULATION OF CELL-GROWTH AND APOPTOSIS IN SYNCHRONIZED AGF CELLS - INVOLVEMENT OF ONCOGENES AND CELL-CYCLE REGULATORY PROTEINS", Blood, 82(10), 1993, pp. 10000524-10000524